Verastem | VSTM - Passifs Courants





Passifs Courants Changement Date
AbbVie USD 41.64B 458M 2026-06
Alaunos Therapeutics USD 595K 218K 2026-03
AstraZeneca USD 31.55B 1.02B 2026-06
Curis USD 14.97M 898K 2026-03
Cytokinetics USD 181.43M 17.76M 2026-06
Gilead Sciences USD 11.02B 1.54B 2026-06
Incyte USD 1.31B 177.55M 2026-06
Laboratory Of America USD 2.12B 516.4M 2026-06
Novartis USD 31.75B 374M 2026-06
Pfizer USD 32.65B 1.7B 2026-06
Roche Holding CHF 28.85B 846M 2026-06
TG Therapeutics USD 268.49M 81.38M 2026-06
Verastem USD 66.84M 5.42M 2026-03